峆一药业：2025年半年度净利润同比增长38.80%

Core Viewpoint - The company reported a significant increase in both revenue and net profit for the first half of 2025, indicating strong financial performance and growth potential [2] Financial Performance - The company achieved operating revenue of 162,628,283.00 yuan, representing a year-on-year growth of 18.35% [2] - The net profit attributable to shareholders of the listed company was 40,425,452.53 yuan, reflecting a year-on-year increase of 38.80% [2]